Cancer Types

Cancer Types

CANCER TYPES

Brain Cancer

Breast Cancer

Herceptin Hylecta Approved for the Treatment of HER2-Overexpressing Breast Cancer

The Food and Drug Administration (FDA) has approved Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for the treatment of HER2-overexpressing breast cancer. Herceptin Hylecta is a combination of trastuzumab, an HER2/neu receptor antagonist, and hyaluronidase, an endoglycosidase used to increase the dispersion and absorption of coadministered drugs when administered subcutaneously. The product contains the same active ingredient…

Cervical Cancer

Colorectal Cancer

Gastrointestinal Cancer

Genitourinary Cancer

Gynecologic Cancer

Head and Neck Cancer

Kidney Cancer

Leukemia

Liver Cancer

Lung Cancer

Lymphoma

Melanoma

Multiple Myeloma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Sarcoma

Skin Cancer

Next post in Leukemia